176 related articles for article (PubMed ID: 33805153)
1. Probiotic
Yeom J; Ma S; Lim YH
Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33805153
[TBL] [Abstract][Full Text] [Related]
2.
Yeom J; Yim DJ; Ma S; Lim YH
Microorganisms; 2021 Dec; 10(1):. PubMed ID: 35056497
[TBL] [Abstract][Full Text] [Related]
3. Antiobesity and antidiabetic effects of the dairy bacterium Propionibacterium freudenreichii MJ2 in high-fat diet-induced obese mice by modulating lipid metabolism.
An M; Park YH; Lim YH
Sci Rep; 2021 Jan; 11(1):2481. PubMed ID: 33510408
[TBL] [Abstract][Full Text] [Related]
4. Surface proteins of Propionibacterium freudenreichii MJ2 inhibit RANKL-induced osteoclast differentiation by lipocalin-2 upregulation and lipocalin-2-mediated NFATc1 inhibition.
Yeom J; Ma S; Yim DJ; Lim YH
Sci Rep; 2023 Sep; 13(1):15644. PubMed ID: 37730858
[TBL] [Abstract][Full Text] [Related]
5. Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization.
Shim KS; Lee B; Ma JY
BMC Complement Altern Med; 2017 Oct; 17(1):483. PubMed ID: 29070038
[TBL] [Abstract][Full Text] [Related]
6. Surface-exposed chaperonin 60 derived from Propionibacterium freudenreichii MJ2 inhibits adipogenesis by decreasing the expression of C/EBPα/PPARγ.
An M; Lim YH
Sci Rep; 2023 Nov; 13(1):19251. PubMed ID: 37935755
[TBL] [Abstract][Full Text] [Related]
7. C-C chemokine receptor type 6 modulates the biological function of osteoblastogenesis by altering the expression levels of Osterix and OPG/RANKL.
Li L; Zhou J; Xu Y; Huang Z; Zhang N; Qiu X; Wang L
Biosci Trends; 2021 Sep; 15(4):240-248. PubMed ID: 34248133
[TBL] [Abstract][Full Text] [Related]
8. microRNA-143-3p regulates odontogenic differentiation of human dental pulp stem cells through regulation of the osteoprotegerin-RANK ligand pathway by targeting RANK.
Yang C; Jia R; Zuo Q; Zheng Y; Wu Q; Luo B; Lin P; Yin L
Exp Physiol; 2020 May; 105(5):876-885. PubMed ID: 32052500
[TBL] [Abstract][Full Text] [Related]
9. RNA Synthesis by DNA Methyltransferase 1 siRNA Transfection with Cationic Liposomes into Osteoblastic Progenitor Cells Based on SiO² Nanomagnetic Beads for Proliferation and Differentiation.
Chen Q; Jiang T; Wang Q; Huang Y; Shao M
J Nanosci Nanotechnol; 2020 Oct; 20(10):6077-6086. PubMed ID: 32384955
[TBL] [Abstract][Full Text] [Related]
10. PTH differentially regulates expression of RANKL and OPG.
Huang JC; Sakata T; Pfleger LL; Bencsik M; Halloran BP; Bikle DD; Nissenson RA
J Bone Miner Res; 2004 Feb; 19(2):235-44. PubMed ID: 14969393
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17A promotes osteogenic differentiation by increasing OPG/RANKL ratio in stem cells from human exfoliated deciduous teeth (SHED).
Sebastian AA; Kannan TP; Norazmi MN; Nurul AA
J Tissue Eng Regen Med; 2018 Aug; 12(8):1856-1866. PubMed ID: 29774992
[TBL] [Abstract][Full Text] [Related]
12. Omentin-1 exerts bone-sparing effect in ovariectomized mice.
Xie H; Xie PL; Luo XH; Wu XP; Zhou HD; Tang SY; Liao EY
Osteoporos Int; 2012 Apr; 23(4):1425-36. PubMed ID: 21755404
[TBL] [Abstract][Full Text] [Related]
13. A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats.
Han X; Gong S; Li N; Wang X; Liu P; Xu Y; He X; Jiang W; Si S
Front Pharmacol; 2019; 10():103. PubMed ID: 30914947
[TBL] [Abstract][Full Text] [Related]
14. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
Humphrey EL; Williams JH; Davie MW; Marshall MJ
Bone; 2006 May; 38(5):652-61. PubMed ID: 16298558
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine alters the osteoprotegerin/RANKL system in the osteoblast to promote bone loss: pivotal role of the redox regulator forkhead O1.
Vijayan V; Khandelwal M; Manglani K; Singh RR; Gupta S; Surolia A
Free Radic Biol Med; 2013 Aug; 61():72-84. PubMed ID: 23500899
[TBL] [Abstract][Full Text] [Related]
16. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
17. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy.
Ndip A; Williams A; Jude EB; Serracino-Inglott F; Richardson S; Smyth JV; Boulton AJ; Alexander MY
Diabetes; 2011 Aug; 60(8):2187-96. PubMed ID: 21659498
[TBL] [Abstract][Full Text] [Related]
18. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
[TBL] [Abstract][Full Text] [Related]
19.
Zhang Y; Liu X; Li K; Bai J
Exp Ther Med; 2015 Mar; 9(3):919-924. PubMed ID: 25667654
[TBL] [Abstract][Full Text] [Related]
20. Leptin can promote mineralization and up-regulate RANKL mRNA expression in osteoblasts from adult female SD rats.
Cheng M; Li T; Li W; Chen Y; Xu W; Xu L
Int J Clin Exp Pathol; 2018; 11(3):1610-1619. PubMed ID: 31938260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
